Adverse event reports following yellow fever vaccination, 2007-13. (Q40098397)

17 September 2017

Adverse event reports following yellow fever vaccination, 2007-13. (English)

1 reference

17 September 2017

0 references

1 reference

5

J Erin Staples

1 reference

17 September 2017

4

Marc Fischer

1 reference

17 September 2017

2

Ingrid B Rabe

1 reference

17 September 2017

1

Nicole P Lindsey

1 reference

17 September 2017

Elaine R Miller

3

1 reference

17 September 2017

1 May 2016

1 reference

Journal of Travel Medicine

17 September 2017

1 reference

17 September 2017

23

1 reference

17 September 2017

5

1 reference

Anaphylaxis from yellow fever vaccine

17 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FJTM%2FTAW045

Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJTM%2FTAW045

Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJTM%2FTAW045

Adverse event reports following yellow fever vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJTM%2FTAW045

Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJTM%2FTAW045

Short report: Incidence of yellow fever vaccine-associated neurotropic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJTM%2FTAW045

Viscerotropic disease following yellow fever vaccination in Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJTM%2FTAW045

Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJTM%2FTAW045

Safety profile of the yellow fever vaccine Stamaril®: a 17-year review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJTM%2FTAW045

Adverse events following yellow fever immunization: Report and analysis of 67 neurological cases in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJTM%2FTAW045

Yellow fever vaccine-associated adverse events following extensive immunization in Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJTM%2FTAW045

The role of the Vaccine Adverse Event Reporting system (VAERS) in monitoring vaccine safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJTM%2FTAW045

Understanding vaccine safety information from the Vaccine Adverse Event Reporting System

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJTM%2FTAW045

Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJTM%2FTAW045

Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJTM%2FTAW045

Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJTM%2FTAW045

Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJTM%2FTAW045

Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJTM%2FTAW045

Advanced Age a Risk Factor for Illness Temporally Associated with Yellow Fever Vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJTM%2FTAW045

Clinical and epidemiological characteristics of yellow fever in Brazil: analysis of reported cases 1998-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJTM%2FTAW045

The reporting sensitivities of two passive surveillance systems for vaccine adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJTM%2FTAW045

21 January 2018

Identifiers

DOI

10.1093/JTM/TAW045

1 reference

17 September 2017

1 reference

PubMed ID

27378369